Clinical trial Recruiting at 2 sites Interventional Ages 15 and up Women only

Using insertable devices to manage obstetric fistula

Official title: Effectiveness and Acceptability of Two Insertable Device Models for Non-surgical Management of Obstetric Fistula: a Randomized Crossover Trial

Run by University of California, San Francisco · NCT05444504 · Data updated 2026-11-12

This study tests whether a new vaginal cup can help women with urinary incontinence from obstetric fistula feel better while they wait for surgery.

Quick facts

Study typeInterventional
Ages15 Years and up
SexWomen only
Enrollment100 (estimated)
SponsorUniversity of California, San Francisco
Academic / other
Locations3 sites (Mankessim and 2 other locations)
StatusRecruiting
StartedApril 15, 2023
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedJuly 14, 2026
Trial IDNCT05444504 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women with confirmed vesicovaginal fistula who are at least 18 years old and willing to use the insertable devices.

Probably not a fit

Patients with rectovaginal fistulas or those who have minimal urinary leakage may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness and acceptability of an insertable vaginal cup for managing urinary incontinence caused by obstetric fistula. Participants will be women awaiting fistula surgery or those whose previous surgery was unsuccessful. The study will compare two intervention models: a standard vaginal cup and a modified version connected to a urine collection bag. The trial will involve a cross-over design with 100 participants observed over four days to assess the performance and user satisfaction of each device.

Why it matters

Potential benefit: If successful, this study could provide a non-surgical management option for women suffering from obstetric fistula-related urinary incontinence.

How similar studies have gone: While the use of insertable devices for menstrual management has been studied, this specific application for obstetric fistula management is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* VVF confirmed by dye test and clinical exam at least 3cm from the external urethral orifice (regardless of size), adequate vaginal capacity to accommodate the cup (per physician)
* Willing to insert and remove cup/cup+
* Clear understanding of the study procedures
* Willing to participate fully, not yet been repaired or previously failed surgical repair, at least 6mo post-surgery
* If previous fistula repair, ≥3mo post-delivery
* If recent birth, age 18+ or emancipated minor
* Speak English or local language

Exclusion criteria:

* Any rectovaginal fistula
* Urinary leakage \<6ml over 6 hours
* Women who are candidates for catheterization who could be healed without surgery will be excluded as they are \<3mo post-delivery.

Where it's running

  • Mercy Women's Catholic Hospital
    Mankessim, Ghana
    Recruiting
  • Tamale Fistula Center
    Tamale, Ghana
    Recruiting
  • Gynocare Women's and fistula hospital
    Eldoret, Kenya
    Enrolling by invitation

Study contacts

  • Principal investigator: Alison El Ayadi, ScD — University of California, San Francisco
  • Study coordinator: Nessa E Ryan, PhD
  • Email: ryann01@nyu.edu
  • Phone: 17048062062

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.